High-Demand Pressor Agent for Surgical & Emergency Use

Restoring Blood Pressure in Hypotensive States

Rapid Sympathomimetic Action via Catecholamine Release

Operation Theatres, ICU, and Post-Spinal Anesthesia

Capture the Critical Care Injectables Segment
Launch Your Mephentermine 30 mg Monopoly Today!

Home/Products /mephentermine-30mg-injection

About the Product

Description


Mephin Injection (Mephentermine 30 mg Injection) is a vital, indirect-acting sympathomimetic agent used primarily as a pressor agent to prevent or treat acute hypotensive states that may occur during spinal anesthesia, surgery, or emergency medical procedures.

Key Commercial Value & Clinical Edge:

  • Critical Indication: It is essential for managing hypotension (low blood pressure) due to hemorrhage, drug reactions, surgical trauma, and especially during obstetric and orthopedic procedures under spinal anesthesia.

  • Rapid Action: Mephentermine acts by causing the release of endogenous catecholamines (Norepinephrine), leading to a rapid and sustained increase in systolic and diastolic blood pressure.

  • Preferred Profile: Unlike some other pressors, Mephentermine maintains renal and cerebral blood flow and has a lower propensity for causing central nervous system (CNS) excitement.

  • Institutional Stock: This is a non-negotiable Schedule H drug required to be stocked in Operation Theatres, ICUs, and Emergency Departments, ensuring consistent institutional purchases.

Secure your exclusive Mephin territory now and establish yourself as a key supplier in the high-value critical care injectables market! 

Transient side effects may include flushing, chest discomfort, shortness of breath, dizziness, or a feeling of warmth. Rarely, it can cause low blood pressure, palpitations, or transient arrhythmias, which usually resolve quickly after the injection. Medical professionals monitor patients closely during administration to ensure safety.

Adenovin Injection is indicated for the rapid conversion of paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm, including those associated with Wolff-Parkinson-White syndrome. It is also used diagnostically to help identify certain types of tachycardias during cardiac evaluation.

Adenovin Injection should be administered only by qualified healthcare professionals in a hospital or clinical setting with cardiac monitoring available. It should not be used for chronic rhythm management. Inform the doctor if the patient has asthma, heart block, or recent heart attack before administration. Avoid caffeine or theophylline before treatment, as these may reduce the drug’s effectiveness.

Store Adenovin Injection at controlled room temperature (below 25°C), away from light and freezing. Do not use if the solution appears discolored or contains particles. Keep out of reach of children and use only under prescription.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Mephentermine 30 mg Injection in the PCD pharma franchise market?

Mephentermine 30 mg Injection is a sympathomimetic drug used for the management of acute hypotension (low blood pressure), especially during surgeries, anesthesia, trauma care, and emergency medical situations. It is a critical-care injectable medicine used mainly in hospitals and operation theatres under strict medical supervision. It is a strong emergency and anesthesia segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this injection in their range?

Medical distributors and wholesalers can benefit from consistent hospital and surgical demand, particularly from operation theatres, ICUs, emergency wards, and anesthesiologists. Critical-care injectables are essential hospital stock items, ensuring stable institutional procurement.

Does Cafoli Lifecore offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in critical-care, anesthesia, and emergency injectable segments with monopoly rights, quality manufacturing standards, and reliable hospital supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this critical-care injectable?

Wholesalers and institutional suppliers benefit from steady hospital procurement, surgical demand, and emergency usage requirements, making it a stable and essential segment when partnered with Cafoli Lifecare.

How can I become a distributor or franchise partner for Mephentermine Injection?

Medical distributors, stockists, and pharma professionals interested in critical-care injectable products can contact Cafoli Lifecare to discuss hospital supply terms, licensing requirements, and PCD pharma franchise opportunities.